Accessing Stiripentol in the US

DSF received notice on the process for patients in the US to secure Diacomit (Stiripentol), effective April 29th. Should patients need Diacomit® before April 29, 2019, they should continue with their current method for medication access, otherwise please refer to the following information:

  •  As of April 29, 2019, patients will need a medical prescription for Diacomit® that must be sent to the specialty care pharmacy, US Bioservices, via fax at (833) 871-4137.
  • US Bioservices will coordinate with the patient and physician to determine the patient’s insurance eligibility and coverage.
  • In the event of no coverage or inadequate coverage, we have designed a generous Patient Assistance Program to help patients gain access to Diacomit®.
  • US Bioservices’ support team will keep the patient informed on the need for additional information and the outcomes of the application.

Biocodex has introduced a dedicated specialty pharmacy program administered by their exclusive partner, US Bioservices. Working closely with prescribers and patients, US Bioservices helps overcome financial barriers and maximize therapy benefits.

If you have any other questions on Diacomit procurement, please contact US Bioservices at (833) 248-0467.